缺氧和铁对前列腺癌细胞系中 Askorbic 酸介导的细胞毒性的影响
Samiksha Deme1, Ida Ramezani1, Jonathan Coulter2
1Department of Environmental Health and Engineering, Bloomberg School of Public Health, Baltimore, MD 21205, United States of America.
Toxicology and applied pharmacology
|February 6, 2025
概括
亚酸 (ASC) 对前列腺癌的有效性在缺氧和铁下降. 这些在瘤中常见的因素可能会限制ASC.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 癌症生物学 癌症生物学
背景情况:
- 亚酸 (ASC) 在体外显示癌症特异性毒性,但体内结果不同.
- 缺氧和铁等外部因素可能会影响ASC的治疗效果.
- 前列腺癌细胞利用雄激素受体通路,与治疗考虑有关.
研究的目的:
- 为了研究缺氧和铁对酸 (ASC) 在前列腺癌中的疗效的影响.
- 为了确定雄激素是否会影响ASC在正常和缺氧的情况下的有效性.
- 了解细胞铁水平如何调节前列腺癌中ASC的细胞毒性.
主要方法:
- 评估ASC的EC50在前列腺癌 (PC-3,DU 145,LNCaP,CWR22Rv1) 和非癌细胞系 (RWPE-1,TERT-PrECs) 中在正常和缺氧条件下.
- 评估了二对ASC疗效的影响.
- 研究了补充铁和费里重链对ASC细胞毒性的作用.
主要成果:
- 缺氧在前列腺癌细胞中增加了ASC的EC50,但不是正常细胞.
- 缺氧降低了对帕克利塔克塞尔的敏感性,但在某些癌症系中没有降低埃托.
- 在PC-3细胞中补充铁增加了ASC的EC50,这种效应没有被费里倒置复制.
结论:
- 缺氧和铁独立地减弱了前列腺癌细胞系中高度ASC的有效性.
- 这些发现表明,瘤微环境因素如缺氧和铁可能会限制ASC的治疗益处.
- 需要进一步的研究来优化基于ASC的疗法,考虑到这些调节因素.
更多相关视频
04:53Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining
Published on: June 23, 2020
30.0K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.3K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Hypoxia
869
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
869
Electron Transport Chain: Complex I and II
10.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.6K
